Daré Bioscience, Inc.
Daré Bioscience, Inc. (DARE) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DARE · as of Sep 30, 2025
Ownership Breakdown
21
Institutional Holders
▼ 3 vs Q2
$2.16M
Total Inst. Value
▼ $4,149 vs Q2
9.52M
Shares Outstanding
freeFloat 98.41%
1.01M
13F Shares Held
▲ 104,833 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DARE largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 394.9K | 4.45% | 4.45% | $829.28M | Nov 7, 2025 | ▲ 66.6K |
AMH EQUITY LTD pharmaceutical preparations | 232.4K | 2.62% | 2.62% | $487.98M | Oct 29, 2025 | ▲ 38.8K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 123.4K | 1.39% | 1.39% | $259.13M | Nov 12, 2025 | ▲ 27.9K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 60.2K | 67.88% | 67.88% | $126.46M | Nov 14, 2025 | ▼ 46.7K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 58.9K | 66.39% | 66.39% | $123.68M | Nov 13, 2025 | ▼ 12.9K |
STATE STREET CORP pharmaceutical preparations | 23.5K | 26.51% | 26.51% | $49.38M | Nov 14, 2025 | — held |
UBS GROUP AG pharmaceutical preparations | 22.6K | 25.50% | 25.50% | $47.50M | Nov 13, 2025 | ▲ 7.6K |
VIRTU FINANCIAL LLC pharmaceutical preparations | 17.7K | 20.00% | 20.00% | $37.00M | Nov 14, 2025 | NEW |
BLACKROCK, INC. pharmaceutical preparations | 17.0K | 19.13% | 19.13% | $35.64M | Nov 12, 2025 | — held |
RAYMOND JAMES FINANCIAL INC pharmaceutical preparations | 15.3K | 17.29% | 17.29% | $32.20M | Nov 14, 2025 | ▲ 13.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
9
Increased
+154.9K shares3
New Positions
first time holders2
Decreased
−59.6K shares7
Sold Out
fully exitedNet shares change (top 50)
+95.3K
+154.9K / −59.6K
Net new holders
+3
3 new / 7 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DARE insider trading · insider activity
Source: SEC Form 4
4
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
JOHNSON SABRINA MARTUCCI Chef Executive Officer | Feb 18, 2026 | Award | 21,600 | $4.00 | $86.4K | 21.6K | Form 4 ↗ |
JOHNSON SABRINA MARTUCCI Chef Executive Officer | Feb 18, 2026 | Award | 10,800 | $2.50 | $27.0K | 10.8K | Form 4 ↗ |
JOHNSON SABRINA MARTUCCI Chef Executive Officer | Jan 30, 2026 | Award | 172,000 | $1.81 | $311.3K | 172.0K | Form 4 ↗ |
Haring-Layton MarDee Chief Accounting Officer | Jan 30, 2026 | Award | 49,000 | $1.81 | $88.7K | 49.0K | Form 4 ↗ |
Haring-Layton MarDee Chief Accounting Officer | Sep 4, 2025 | Award | 57,000 | $2.13 | $121.4K | 57.0K | Form 4 ↗ |
RASTETTER WILLIAM H director | Jul 9, 2025 | Award | 4,500 | $2.44 | $11.0K | 4.5K | Form 4 ↗ |
Steele Robin Joan director | Jul 9, 2025 | Award | 4,500 | $2.44 | $11.0K | 4.5K | Form 4 ↗ |
Matz Gregory W director | Jul 9, 2025 | Award | 4,500 | $2.44 | $11.0K | 4.5K | Form 4 ↗ |
Grossman Jessica D. director | Jul 9, 2025 | Award | 4,500 | $2.44 | $11.0K | 4.5K | Form 4 ↗ |
Kelley Susan L. director | Jul 9, 2025 | Award | 4,500 | $2.44 | $11.0K | 4.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Daré Bioscience, Inc. (DARE) is primarily owned by institutional investors, who hold approximately 10.6% of total shares outstanding. Company insiders own approximately 1.59%, while retail and public investors account for the remaining 87.81%.
The largest institutional shareholder of Daré Bioscience, Inc. is VANGUARD GROUP INC, holding approximately 394,897 shares — equal to 4.45% of outstanding shares — as of September 30, 2025.
A total of 21 institutional investors currently hold DARE stock, with a combined institutional value of approximately $2,157,900 as of the most recent 13F filing period.
Frequently asked questions
DARE ownershipDaré Bioscience, Inc. (DARE) is primarily owned by institutional investors, who hold approximately 10.6% of shares. The largest shareholder is VANGUARD GROUP INC with a 4.45% stake. Company insiders hold 1.59%. Data sourced from SEC Form 13F as of September 30, 2025.